人绒毛膜促性腺激素与子痫前期风险:前瞻性人群队列研究
该前瞻性人群队列纳入7754例单胎妊娠孕妇,检测孕早期总hCG及孕早、中期sFlt-1/PlGF比值。高hCG与子痫前期风险增加1.5-2.7倍相关(P=0.0001),且与孕早期sFlt-1/PlGF比值升高相关(P<0.0001);校正孕早期sFlt-1/PlGF比值后,高hCG与子痫前期的关联减弱约40%。
要点
- 孕早期总hCG升高与子痫前期风险增加1.5-2.7倍相关,具体倍数取决于所用切点。
- 高hCG与孕早期sFlt-1/PlGF比值升高相关(P<0.0001)。
- 校正孕早期sFlt-1/PlGF比值后,高hCG与子痫前期的关联减弱约40%。
核心结论
- 孕早期总hCG浓度升高与子痫前期风险增加相关;高hCG对促血管生成与抗血管生成因子平衡的影响可能在子痫前期病理生理中起作用。
研究设计与样本
- 前瞻性人群队列研究,纳入7754例单胎妊娠孕妇;总hCG于首个可用样本中检测(中位孕周14.4周,95%范围10.1-26.1周),sFlt-1与PlGF于孕早期(<18周;中位13.2周,95%范围9.6-17.6周)和孕中期(18-25周;中位20.4周,95%范围18.5-23.5周)检测;采用回归分析,校正母亲年龄、种族、体重指数、产次、教育水平、吸烟状态及胎儿性别。
诊断标准与关键数值
- 高hCG浓度与子痫前期风险增加1.5-2.7倍相关(P=0.0001),具体倍数取决于所用切点。
- 高hCG与孕早期sFlt-1/PlGF比值升高相关(P<0.0001)。
- 校正孕早期sFlt-1/PlGF比值后,高hCG与子痫前期的关联减弱约40%(β估计值从0.19±0.10,P=0.052,变为0.12±0.10,P=0.22)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Abnormal placentation in early pregnancy may play a role in the pathogenesis of pre-eclampsia. Human chorionic gonadotropin (hCG) regulates placental development and angiogenesis and may affect the ratio of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) in the serum. The aims of this study were to investigate the association of total hCG with the risk of pre-eclampsia and to examine the potential effect of pro- and anti-angiogenic factors on this association.
METHODS: This was a population-based prospective cohort study of 7754 women with a singleton pregnancy. Total hCG was measured in the first available sample (median gestational age, 14.4 weeks; 95% range, 10.1-26.1 weeks) and sFlt-1 and PlGF concentrations in early (< 18 weeks; median, 13.2 weeks; 95% range, 9.6-17.6 weeks) and in mid- (18-25 weeks; median, 20.4 weeks; 95% range, 18.5-23.5 weeks) pregnancy. We tested the association of hCG concentration and risk of pre-eclampsia using regression analysis, adjusting for maternal age, ethnicity, body mass index, parity, education level, smoking status and fetal sex. Additionally, we assessed whether this association was affected by the sFlt-1/PlGF ratio.
RESULTS: High hCG concentration was associated with a 1.5-2.7-fold increased risk of pre-eclampsia (P = 0.0001), depending on the cut-off used, and with increased sFlt-1/PlGF ratio during early pregnancy (P < 0.0001). The association between high hCG and pre-eclampsia attenuated by roughly 40% after adjustment for early-pregnancy sFlt-1/PlGF ratio (β-estimate change from 0.19 ± 0.10 (P = 0.052) to 0.12 ± 0.10 (P = 0.22)).
CONCLUSIONS: High total hCG concentration in early pregnancy is associated with an increased risk of pre-eclampsia. The effect of high hCG concentration on the balance between pro- and anti-angiogenic factors during pregnancy may have a role in the pathophysiology of pre-eclampsia. © 2019 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Barjaktarovic M, Korevaar TIM, Jaddoe VWV, et al. Human chorionic gonadotropin and risk of pre-eclampsia: prospective population-based cohort study. Ultrasound Obstet Gynecol. 2019. PMID: 30834627. doi:10.1002/uog.20256
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。